tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
GDTC
CytoMed Therapeutics Limited
RESEARCH TOOLSreports
Want to see GDTC full AI Analyst Report?

CytoMed Therapeutics Limited (GDTC) Financial Statements

23 Followers

CytoMed Therapeutics Limited Financial Overview

CytoMed Therapeutics Limited's market cap is currently $11.95M. The company's EPS TTM is $; its P/E ratio is -2.79; CytoMed Therapeutics Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total RevenueS$ 319.20KS$ 69.50KS$ 509.13KS$ 365.60KS$ 0.00
Gross Profit-S$ 52.38KS$ 505.39KS$ -109.04KS$ 110.29K
Operating IncomeS$ -4.52MS$ -3.13M-S$ -2.28MS$ -1.16M
EBITDAS$ -4.30MS$ -2.44MS$ -3.89MS$ -1.47MS$ -1.42M
Net IncomeS$ -3.92MS$ -2.57MS$ -4.14MS$ -3.06MS$ -2.07M
Balance Sheet
Cash & Short-Term InvestmentsS$ 2.10MS$ 4.97MS$ 9.02MS$ 1.59MS$ 2.53M
Total AssetsS$ 7.98MS$ 10.07MS$ 12.40MS$ 5.25MS$ 6.10M
Total DebtS$ 482.56KS$ 463.15KS$ 449.25KS$ 4.24MS$ 3.27M
Net DebtS$ -1.61MS$ -4.51MS$ -8.57MS$ 2.65MS$ 747.67K
Total LiabilitiesS$ 1.13MS$ 1.02MS$ 1.13MS$ 4.66MS$ 3.50M
Stockholders' EquityS$ 6.54MS$ 8.96MS$ 11.28MS$ 589.71KS$ 2.60M
Cash Flow
Free Cash FlowS$ -4.40MS$ -4.11MS$ -3.60MS$ -1.88MS$ -2.30M
Operating Cash FlowS$ -3.70MS$ -2.71MS$ -3.54MS$ -1.40MS$ -1.72M
Investing Cash FlowS$ 929.28KS$ 675.32KS$ -2.79MS$ -475.51KS$ -825.59K
Financing Cash FlowS$ 208.65KS$ -45.55KS$ 10.80MS$ 968.72KS$ 4.18M
Currency in SGD

CytoMed Therapeutics Limited Earnings and Revenue History

Income Statement >

CytoMed Therapeutics Limited Debt to Assets

Balance Sheet >

CytoMed Therapeutics Limited Cash Flow

Cash Flow >

CytoMed Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >